BOSTON, Oct. 26 /PRNewswire/ -- A unique product line of Scanning Laser
Ophthalmoscopes (SLO's) developed by Odyssey Optical Systems will be shown to
ophthalmologists during the American Academy of Ophthalmology annual
convention in New Orleans (November 8 - 11).
    The initial product was approved by the U.S. Food and Drug Administration
(FDA) in August 1998.  This SLO system is the first of three new models which
utilize diode lasers and advanced imaging technologies for diagnosing,
monitoring, and treating retinal disease before it can destroy a patient's
vision.  It is also the lowest-price SLO ever commercialized -- making this
sight-saving instrument available to thousands of eyecare providers that could
not afford the high-priced systems currently on the market.
    Odyssey will also introduce a hand-held Ophthalmoscope, and a PocketScope
device at the AAO convention.  The hand-held ophthalmoscope is expected to
sell for less than $2,500.  And the PocketScope, a battery-powered
miniaturized replacement for direct ophthalmoscopes, could sell for less than
$600.  FDA approval is pending on these two devices.
    Odyssey Optical Systems, based in Boston, is dedicated to the rapid
commercialization of this combination therapeutic/diagnostic SLO technology.
Odyssey participates in the ophthalmic laser market along with several other
successful laser companies including: Coherent (Nasdaq: COHR), Iridex
(Nasdaq: IRIX), and VISX (Nasdaq: VISX).
    For more information, contact Adrian Grundy at: 617-720-5254.

Link to this page: